Description
The industry’s first app where clinical trial participants can record data in the comfort and convenience of their own homes, collected as part of their designated study protocol. Participants can customize their reminder push notifications, so they always know when to record elements such as:
-ECGs
-Symptoms
-Blood Pressure
-Capture pictures
Hide
Show More...
-ECGs
-Symptoms
-Blood Pressure
-Capture pictures
Screenshots
ICON DCT+ FAQ
-
Is ICON DCT+ free?
Yes, ICON DCT+ is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is ICON DCT+ legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does ICON DCT+ cost?
ICON DCT+ is free.
-
What is ICON DCT+ revenue?
To get estimated revenue of ICON DCT+ app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Brazil yet.
Ratings History
ICON DCT+ Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
ICON DCT+ Installs
Last 30 days
ICON DCT+ Revenue
Last 30 daysICON DCT+ Revenue and Downloads
Gain valuable insights into ICON DCT+ performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- ICON
- Languages
- English
- Recent release
- 1.1.0 (11 months ago )
- Released on
- May 18, 2022 (2 years ago )
- Also available in
- New Zealand, Ireland, India, Italy, Japan, South Korea, Kuwait, Lebanon, Malaysia, Nigeria, Netherlands, Indonesia, Philippines, Poland, Russia, Saudi Arabia, Sweden, Türkiye, Ukraine, United States, Vietnam, South Africa, Dominican Republic, Austria, Australia, Azerbaijan, Belgium, Brazil, Canada, China, Czechia, Germany, Denmark, Argentina, Algeria, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Hungary, Hong Kong SAR China
- Last Updated
- 1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.